#AIBT AIBT enhances target screening efficiency by 90% through AI simulation of molecular structures, making the development of drugs for rare diseases go from "out of reach" to "within reach."

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.